The ER became the target for tamoxifen to treat breast cancer (Jordan & Koerner 1975) based on the National Cancer Instituteconsensus conference in Bethesda in 1974 on ERs in human breast cancer (McGuire et al. 1975). Here, ESR1 is linked to breast cancer.